NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP equivalent to Atorvastatin 20 mg + Clopidogrel Bisulphate IP equivalent to Clopidogrel 75 mg for M/s Sun Pharma Laboratories Limited (Manufacturer & Marketer)

Jun 17, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 13, 2026, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP equivalent to Atorvastatin 20 mg + Clopidogrel Bisulphate IP equivalent to Clopidogrel 75 mg for M/s Sun Pharma Laboratories Limited (Manufacturer & Marketer).

It states that the price for each uncoated bilayer tablet containing Atorvastatin Calcium IP equivalent to Atorvastatin 20 mg + Clopidogrel Bisulphate IP equivalent to Clopidogrel 75 mg has been fixed at Rs. 15.01/- excluding GST.

[Notification no. - 19(5173)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT